Scout Investments’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-614,307
| Closed | -$2.21M | – | 209 |
|
2023
Q3 | $2.21M | Sell |
614,307
-17,829
| -3% | -$64.2K | 0.05% | 209 |
|
2023
Q2 | $2.86M | Sell |
632,136
-18,814
| -3% | -$85.2K | 0.06% | 208 |
|
2023
Q1 | $4.45M | Sell |
650,950
-7,688
| -1% | -$52.6K | 0.09% | 190 |
|
2022
Q4 | $5.22M | Sell |
658,638
-10,748
| -2% | -$85.1K | 0.11% | 185 |
|
2022
Q3 | $6.43M | Sell |
669,386
-18,940
| -3% | -$182K | 0.13% | 175 |
|
2022
Q2 | $4.98M | Buy |
688,326
+92,739
| +16% | +$671K | 0.1% | 192 |
|
2022
Q1 | $7.69M | Sell |
595,587
-773
| -0.1% | -$9.98K | 0.12% | 181 |
|
2021
Q4 | $9.52M | Sell |
596,360
-13,378
| -2% | -$214K | 0.14% | 193 |
|
2021
Q3 | $9.8M | Sell |
609,738
-15,831
| -3% | -$254K | 0.15% | 195 |
|
2021
Q2 | $8.65M | Buy |
625,569
+74,618
| +14% | +$1.03M | 0.13% | 210 |
|
2021
Q1 | $8.05M | Buy |
+550,951
| New | +$8.05M | 0.12% | 234 |
|